Nyhet -

Karolinska Institutet Science Park DAY 2014, April 29 – Success Stories and Business Opportunities

Welcome to Karolinska Institutet Science Park DAY 2014, an entire afternoon filled with success stories and business opportunities. You will get to meet exiting life science companies ready to take the next step to pursue the development of new therapies, innovative diagnostics and medical technologies.

Karolinska Institutet Science Park DAY 2014 will be hosted by Magnus Persson, chairman of Karolinska Institutet Innovations, and the keynote talk will be given by Dr. Gerd Maass, Head of Strategic Partnerships at Roche Pharma AG.

Presenting companies:
AB Mando, an innovative healthcare company specialized in treating eating disorders with its own patented technology.

Aprea, who are on track in developing a novel cancer therapy targeting cells with mutation of the p53 gene.

Clanotech, with ophthalmology projects currently in preclinical phase and intended to enter clinical trial during 2014.

InDex Pharmaceuticals, an immunology focused biopharmaceutical company with, among other things, a candidate currently in a Phase III trial in severe treatment refractory Ulcerative Colitis.

Liquid Biopsy, developing instruments for today’s medical cytology and tomorrow's individualized cell-based cancer diagnostics.

Neurovive Pharmaceutical, a world leader in developing cyclosporine-based mitochondrial-protecting pharmaceuticals.

NKure is a new cell therapy project using selectively expanded natural killer cells for the treatment of leukaemia.

Pharmanest, a pharmaceutical company specialized in developing products for local pain relief in obstetrics and gynecology.

Umecrine Mood develops unique and novel products based on modulation of GABA-steroid action for the treatment of Premenstrual Dysphoric Disorder. The company´s drug candidate is currently in clinical phase II.

XSpray Microparticles, a drug delivery company that specializes in optimizing the performance of challenging drug substances.

Time: 1 pm – 6 pm, April 29th
Venue: KI Science Park’s Gamma Building, Tomtebodavägen 23a, Stockholm – Click here for directions

Registration and Program here.

Ämnen

  • Medicinsk forskning

Kategorier

  • ki science park day
  • medtech
  • pharmaceuticals
  • vaccine
  • drug delivery
  • diagnostics
  • life science

Regioner

  • Stockholm

Kontakter

Anders Flodin

Presskontakt VD, Karolinska Institutet Holding AB 073-370 81 55

Relaterat innehåll

Sveriges hetaste bioteknikföretag finns i KI Science Park

KI Science Park-företaget InDex Pharmaceuticals toppar Veckans Affärers lista över de hetaste bioteknikföretagen. Drygt ett av fyra av de listade företagen kommer från Karolinska Institutet Science Park. – Jag ser det som ett kvitto på att vi erbjuder Sveriges mest fruktbara miljö för innovativa life science-företag, säger Märit Johansson, VD för KI Science Park.

KI Science Park satsar för att hitta rätt investerare till allt fler växande bolag

Karolinska Institutet Science Park DAY anordnas i år på Nobel Forum vid Karolinska Institutet i Solna och programmet den 17 april är fullmatat. – Ett värdefullt tillfälle att knyta kontakter som kan ge ett långsiktigt stöd även i senare utvecklingsfaser, säger Pirkko Sulila Tamsen, vd för KI Science Park-företaget Dilaforette.